SCHEMBL6179907

SCHEMBL6179907

CC(C)Cc1nc(-c2ccccc2)cn1-c1ccc(CCO[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
NR1H2 P55055 1/20 0.34
AGER Q15109 4/20 0.32
PDE10A Q9Y233 4/20 0.32
CXCR3 P49682 4/20 0.32
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
HTT P42858 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
PRKACA P17612 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179637 0.89 SMN1; SMN2 (0.37) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL6253206 0.86 AGER (0.46) LMNANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6174783 0.84 PTGS2 (0.44) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL6329377 0.84 SMN1; SMN2 (0.38) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL6176741 0.84 GPR119 (0.41) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL6173167 0.80 LMNA (0.39) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL4453125 0.78 MAPT (0.39) LMNAMEN1KMT2ANPC1RAB9A
SCHEMBL6178027 0.74 NPC1 (0.50) NPC1RAB9A
SCHEMBL9185281 0.70 IDO1 (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL6177327 0.67 SPNS2 (0.43) LMNAMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956050-B2 Imidazole compounds as anti-inflammatory and analgesic agents PFIZER, INC. (US) 2005-10-18 US disclosed
EP-1494667-A1 IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS Pfizer Japan Inc. (JP) 2005-01-12 EP disclosed
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents HIRANO MISATO (JP) 2003-11-27 US disclosed
WO-2003086390-A1 IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220372-A1 Imidazole compounds as anti-inflammatory and analgesic agents PTGS1, PTGS2, PTGES LMNA 4151/4885MEN1 4244/4885KMT2A 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.